University of Arizona's Health Science: RAIVEN Study Will Examine Efficacy of Flu Vaccines
September 14, 2022
September 14, 2022
TUCSON, Arizona, Sept. 14 (TNSres) -- The University of Arizona's Health Science issued the following news release:
* * *
People ages 18-64 can participate in the Randomized Assessment of Influenza Vaccine Efficacy Network study through a regional site led by University of Arizona Health Sciences researchers.
* * *
University of Arizona Health Sciences researchers will conduct a phase 4 clinical trial to assess how well two different influ . . .
* * *
People ages 18-64 can participate in the Randomized Assessment of Influenza Vaccine Efficacy Network study through a regional site led by University of Arizona Health Sciences researchers.
* * *
University of Arizona Health Sciences researchers will conduct a phase 4 clinical trial to assess how well two different influ . . .